DAVID M MOTT Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of DAVID M MOTT for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.43 | 52,473 | 652,134 | 0 | 52.5 K to 0 (-100.00 %) |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.85 | 52,472 | 674,176 | 52,473 | 104.9 K to 52.5 K (-50.00 %) |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 13.31 | 52,472 | 698,649 | 104,945 | 157.4 K to 104.9 K (-33.33 %) |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 157,417 | 0 | 157,417 | 0 to 157.4 K |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 38,646 | 0 | 39,297 | 651 to 39.3 K (+5,936.41 %) |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 767,500 | 0 | 0 | 767.5 K to 0 (-100.00 %) |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 767,500 | 0 | 767,500 | 0 to 767.5 K |
| Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 2,500,000 | 0 | 3,971,018 | 6.5 M to 4 M (-38.63 %) |
| Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MOTT DAVID M | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
| Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | MOTT DAVID M | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
| Jun 17 2019 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
| Jun 17 2019 | ARDX | ARDELYX, INC. | MOTT DAVID M | Director | Grant | A | 0.00 | 32,846 | 0 | 87,566 | 54.7 K to 87.6 K (+60.03 %) |
| Jun 11 2019 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 4.31 | 25,000 | 107,750 | 25,000 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 12.39 | 1,891 | 23,429 | 13,979 | 12.1 K to 14 K (+15.64 %) |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | MOTT DAVID M | Director | Option Exercise | D | 13.57 | 21,000 | 284,970 | 0 | |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | MOTT DAVID M | Director | Option Exercise | D | 12.27 | 36,400 | 446,628 | 0 | |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | MOTT DAVID M | Director | Sell | D | 25.50 | 6,662,532 | 169,894,566 | 0 | 6.7 M to 0 (-100.00 %) |